Hemostasis Diagnostics

Hemostasis Diagnostics Market By Product Type (Laboratory Systems, Consumables, Point-of-Care Testing Systems), By Test Type (Prothrombin Time, Activated Partial Thromboplastin Time, Fibrinogen Degradation Products, Activated Clotting Time, Platelet Aggregation Test, D Dimer), Industry Analysis, Trends, and Forecast 2020-2025

  • Report ID: BMRC 256 | Number of pages: 200 | Publish Date: Dec 2019
    Status: Published | Category: Healthcare | Delivery Timeline: 48 hrs


COVID-19
To know the impact of COVID-19 On Hemostasis Diagnostics Market By Product Type (Laboratory Systems, Consumables, Point-of-Care Testing Systems), By Test Type (Prothrombin Time, Activated Partial Thromboplastin Time, Fibrinogen Degradation Products, Activated Clotting Time, Platelet Aggregation Test, D Dimer), Industry Analysis, Trends, and Forecast 2020-2025 Market

Request Now

Market Size Graph


Hemostasis Diagnostics Market is valued around USD 2228.8 Million in 2018 and expected to reach USD 3948.6 Million by 2025 with the CAGR of 8.1% over the forecast period.

Increased prevalence of blood clotting disorders and increase in technological advancements are the key drivers for Global Hemostasis Diagnostics Market.

Market Analysis of Hemostasis Diagnostics -

Hemostasis Diagnostics market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about hemostasis diagnostics market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of hemostasis diagnostics market. This report consists of regional segmentation with product type, test type, and end use.

Hemostasis diagnostic are those devices which help in the identification of hemostatic defects which leads to excessive bleeding. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis is a mechanism followed by the body after getting injured, it slows down the blood loss and stop the blood flow. This process is followed by three steps which include vasoconstriction, platelet plug formation and blood coagulation. Hemostasis helps in the diagnosis of actual cause of these disorders with history and helps in the treatment.

Hemostasis diagnostics market report is segmented based on product type, test type, end users and by regional & country level. Based upon product type, hemostasis diagnostics market is classified into laboratory systems, consumables, point-of-care testing systems. Based upon test type, hemostasis diagnostics market is classified into prothrombin time, activated partial thromboplastin time, fibrinogen degradation products, activated clotting time, platelet aggregation test and D dimer. Based upon end users, hemostasis diagnostics market is classified into hospital/clinics, independent diagnostic, laboratories and other.

The regions covered in this hemostasis diagnostics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of hemostasis diagnostics is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Hemostasis Diagnostics Companies

Hemostasis diagnostics market report covers prominent players like,

Abbott Laboratories

F. Hoffmann-La Roche Ltd.

Nihon Kohden Corporation

Thermo fisher Scientific Inc

Danaher Corporation

Sysmex Corporation

Siemens Healthineers

Alere Inc.

Instrumentation Laboratory

Grifols S.A

Others

Hemostasis Diagnostics Market are those devices which help in the identification of hemostatic defects which leads to excessive bleeding. Hemostasis is a mechanism followed by the body after getting injured, it slows down the blood loss and stop the blood flow. This process is followed by three steps which include vasoconstriction, platelet plug formation and blood coagulation. Hemostasis helps in the diagnosis of actual cause of these disorders with history and helps in the treatment.

 

Haemonetics acquires blood coagulation testing system developer Enicor

News: April 3, 2020, Hemonetics announced that it acquired next-generation whole blood coagulation testing system developer Enicor for an undisclosed amount. Munich, Germany-based Enicor develops the ClotPro system designed for viscoelastic diagnostics touted to offer more assays than any other hemostasis analyzer on the market. As per the Haemonetics, ClotPro is set to be coupled with its TEG 5000 hemostasis analyzer and TEG 6s hemostasis analyzer with site-of-care technology.

Hemostasis Diagnostics Market Dynamics –

Rising prevalence of disease driving the growth of market. As per the report by the World Health Organization, around 400, 000 people worldwide suffer from hemophilia, of which 56% remain undiagnosed. This will flourish the growth of the hemostasis diagnostics market. Additionally, technological advancement leading to the development of novel advanced products for hemostasis. This helps healthcare professionals to perform varied tasks and bring about efficiency and efficacy in hemostasis diagnostics. On the other flip less awareness about disease in certain region may restrain the growth of market. Nevertheless, increasing government initiative are expected to create lucrative opportunity in the market.

Hemostasis Diagnostics Market Regional Analysis –

North America dominates the market and expected to share highest market over the forecast period. The dominance of this region is due to the increased healthcare infrastructure, and the presence of large patient pool and high adoption of advanced automated analyzers. In addition, high spending on healthcare helps to dominate the region, for instance, U.S. health care spending grew 4.6 percent in 2018, reaching around USD 3.6 trillion or USD 11,172 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 17.7 percent.

The Asia-Pacific is expected to witness the fastest growth over the forecast period owing to currently undergoing a paradigm shift and are investing huge amount of government funds to procure and install such medical devices into their public healthcare facilities. Additionally, increasing awareness and presence of a huge patient pool in developing economies such as India and China can further fuel the regional demand.

Key Benefits for Hemostasis Diagnostics Market Reports –

Global Market report covers in depth historical and forecast analysis.

Global Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global Market report helps to identify opportunities in market place.

Global Market report covers extensive analysis of emerging trends and competitive landscape.

Hemostasis Diagnostics Market Segmentation –

By Product Type: Laboratory Systems, Consumables, Point-of-Care Testing Systems

By Test Type: Prothrombin Time, Activated Partial Thromboplastin Time, Fibrinogen Degradation Products, Activated Clotting Time, Platelet Aggregation Test, D Dimer

By End User: Hospital/Clinics, Independent Diagnostic, Laboratories, Other

Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa.


Frequently Asked Questions (FAQ) :
Hemostasis Diagnostics Market is valued around USD 2228.8 Million in 2018 and expected to reach USD 3948.6 Million by 2025 with the CAGR of 8.1%
By Product Type- (Laboratory Systems, Consumables, Point-of-Care Testing Systems),  By Test Type- (Prothrombin Time, Activated Partial Thromboplastin Time, Fibrinogen Degradation Products, Activated Clotting Time, Platelet Aggregation Test, D Dimer), By End User- (Hospital/Clinics, Independent Diagnostic, Laboratories, Other)
North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa
report covers prominent players like Abbott Laboratories, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Thermo fisher Scientific Inc., Danaher Corporation, Sysmex Corporation, Siemens Healthineers, Alere Inc., Instrumentation Laboratory, Grifols S.A. and others.



Interested in this report?

Hemostasis Diagnostics Market Size Overview to 2020 - 2025 and Analysis 2019-2025

report cover

  1. Chapter – Report Methodology
    Research Process
    Primary Research
    Secondary Research
    Market Size Estimates
    Data Triangulation
    Forecast Model
    USP’s of Report
    Report Description
  2. Chapter – Global Hemostasis Diagnostics Market Overview: Qualitative Analysis
    Market Introduction
    Executive Summary
    Global Hemostasis Diagnostics Market Classification
    Market Drivers
    Market Restraints
    Market Opportunity
    Hemostasis Diagnostics Market: Trends
    Porter’s Five Forces Analysis
    Bargaining Power of Suppliers
    Bargaining Power of Consumers
    Threat of New Entrants
    Threat of Substitute Product and Services
    Competitive Rivalry within the Industry
    Market Attractiveness Analysis
    Market Attractiveness Analysis by Segmentation
    Market Attractiveness Analysis by Region
  3. Chapter – Global Hemostasis Diagnostics Market Overview: Quantitative Analysis
    Global Hemostasis Diagnostics Market Consumption, Market Share ( %) and Growth Rate, 2015- 2025
    Global Hemostasis Diagnostics Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2015- 2025
  4. Chapter – Global Hemostasis Diagnostics Market Analysis: by Product Type
  5. Chapter – Global Hemostasis Diagnostics Market Analysis: by Test Type
  6. Chapter – Global Hemostasis Diagnostics Market Analysis: by End User
  7. Chapter – Global Hemostasis Diagnostics Market Analysis: by Manufacturer
    Global Hemostasis Diagnostics Market Revenue (USD Million), by Manufacturer, 2015-2018
    Global Hemostasis Diagnostics Market Consumption, Manufacturer, 2015-2018
    Global Hemostasis Diagnostics Market Share (%), by Manufacturer, 2018
    Global Hemostasis Diagnostics Market Price (USD/Unit), by Manufacturer, 2015-2018
    Global Hemostasis Diagnostics Market Revenue Growth Rate (%), by Manufacturer, 2015-2018
    Merger & Acquisition
    Collaborations and Partnership
    New Product Launch
  8. Chapter – Hemostasis Diagnostics Market: Regional Analysis
    North America
    North America Hemostasis Diagnostics Market Revenue (USD Million) and Growth Rate (%), 2015-2025.
    North America Hemostasis Diagnostics Market Revenue (USD Million) By Country, 2015-2025.
    North America Hemostasis Diagnostics Revenue Market Share (%) By Country, 2015-2025.
    North America Hemostasis Diagnostics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
    North America Hemostasis Diagnostics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
    North America Hemostasis Diagnostics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
    Europe
    Asia Pacific
    Latin America
    Middle East & Africa

  9. Chapter – Company Profiles
    Abbott Laboratories
    Overview
    Financials
    Product portfolio
    Hemostasis Diagnostics Market Revenue (USD Million), Consumption  and Market Share (%), 2015 – 2018
    Hemostasis Diagnostics Sales Market Share (%), 2015 – 2018
    Business strategy
    Recent developments
    Hoffmann-La Roche Ltd.
    Nihon Kohden Corporation
    Thermo fisher Scientific Inc.
    Danaher Corporation
    Sysmex Corporation
    Siemens Healthineers
    Alere Inc.
    Instrumentation Laboratory
    Grifols S.A.
    Others
  10. Chapter – Market Research and Findings

 

Hemostasis Diagnostics Market By Product Type (Laboratory Systems, Consumables, Point-of-Care Testing Systems), By Test Type (Prothrombin Time, Activated Partial Thromboplastin Time, Fibrinogen Degradation Products, Activated Clotting Time, Platelet Aggregation Test, D Dimer), Industry Analysis, Trends, and Forecast 2020-2025

  • Full Name * :
  • Bussiness Email * :
  • Job Title :
  • Company :
  • Contact No * :
  • Country * :
  • Any Query * :
  • Captcha * :
Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Choose License Type ( Price )

Single user license, allowing one specific user access to the product.
Multi-users license, allowing up to five users access to the product.
Corporte license . Allows all employees within your organization to access product.


American Express Citi Bank Credit/Debit Card Maestro Payment Master Card PayPal Visa Wire Transfer

+44-1173181773
alan@brandessenceresearch.biz


Looking for Regional Reports?